Kartavya Pawar

Drug regulatory affairs - Officer at Ajanta Pharma | CDSCO/ DCGI | India market | Indian regulatory affairs | EX- Ipca laboratories

Role: Drug Regulatory Affairs Officer - Dcgi at Ajanta Pharma Ltd
Location: Mumbai, MH, IN
LinkedIn followers: 500 followers

ScienceView LinkedIn profile

About Kartavya Pawar

I had completed B. Pharmacy from Mumbai University. I am currently working as a Medico-…

Experience

Drug Regulatory Affairs Officer - Dcgi
Ajanta Pharma Ltd
Jul 2025 — Present · Mumbai, IN

Education

Konkan Gyanpeeths Rahul Dharkar College of Pharmacy and Research Institute Vengaon Road Dahivali Karjat Dist Raigad 410 201
Konkan gyaanpeeth rahul dharkar college of pharmacy and Research institute karjat
2019 — 2023
Janata Junior College Khopoli
HSC
2017 — 2019
Janta vidhyalay khopoli
SSC
2016 — 2017

Contact information

Verified work emails, personal emails, and direct dials — unlocked in one click.

Work email
•••••@ajantapharma.com
Personal email
•••••@•••••.com
Direct dial
+•• ••• ••• ••••

Unlock verified contacts

Free to start · No credit card required

Current company

Ajanta Pharma Ltd

Pharmaceutical Manufacturing · 10K employees · Founded 1973 · Ajanta Tower, 54-A, M Vasanji Road, Chakala, Andheri (E), IN

Ajanta Pharma Limited is a pharmaceutical company headquartered in Mumbai, India. It has strong presence in Branded Generic business in India & Emerging markets; and Generic business in USA. In India, company operates in selected therapeutic areas of Cardiology, Dermatology, Ophthalmology, and Pain management. Recently Ajanta also got into two new promising therapies of Nephrology and Gynaecology. Its brands hold leadership positions in sub-therapeutic areas they are present in. In Emerging Markets, company has presence in Africa, South East Asia, West Asia, and CIS on broader therapeutic segments such as antimalarial, gastro, antibiotics, cardiology, dermatology, pain management, etc. As on 30th Mar 2026, Ajanta has 49 ANDA approvals, out of which 49 are commercialised. It is awaiting US FDA approval for 19 ANDAs. Company plans to file 8-12 ANDAs every year. Company has state-of-the-art research facilities for formulation and API development located at Mumbai, India. R&D capabilities are evident from number of 1st to market products launched by the company providing patients most needed compliance and convenience. A dedicated and focused team of over 850 scientists work for R&D, which is growing continuously. Ajanta has 6 formulations manufacturing facilities located in India. Besides that, it also has an API manufacturing facility located at Waluj, India. Ajanta’s flagship formulation facilities at Paithan (Maharashtra, India) and Dahej (Gujarat, India) have been approved by US FDA. Ajanta continuously invests in enhancing the existing manufacturing facilities to meet current cGMP requirements and also construct new facilities to meet company’s growth requirements. Please visit https://ajantapharma.com/ for more information.

ajantapharma.com

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Start for free See how it works

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

About Kartavya Pawar

Experience

Drug Regulatory Affairs Officer - Dcgi

Education

Konkan Gyanpeeths Rahul Dharkar College of Pharmacy and Research Institute Vengaon Road Dahivali Karjat Dist Raigad 410 201

Janata Junior College Khopoli

Janta vidhyalay khopoli

Find verified contacts for anyone on LinkedIn